137 results on '"Dudani, Renu"'
Search Results
2. Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
3. Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
4. Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern
5. Synthesis of sulfated lactosyl glycosides for evaluation in vaccine adjuvant formulations.
6. Self-Amplifying RNA Generated with the Modified Nucleotides 5-MethylCytidine and 5-MethylUridine Mediate Strong Expression & Immunogenicity in vivo
7. Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters
8. Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
9. A Method to Evaluate In Vivo CD8+ T Cell Cytotoxicity in a Murine Model
10. Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious
11. Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern
12. Blood-Based Immune Protein Markers of Disease Progression in Murine Models of Acute and Chronic Inflammatory Bowel Disease
13. Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
14. Effect of Chiral Purity on Adjuvanticity of Archaeol-Based Glycolipids
15. Modulation of Antigenic Location Converts Chronic into Acute Infection by Forcing CD8+ T Cell Recognition
16. Intranasal Immunization with a Proteosome-Adjuvanted SARS-CoV2 Spike Protein-Based Vaccine is Immunogenic and Efficacious in Mice & Hamsters
17. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium
18. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model
19. The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model
20. Pre‐clinical development of a blood‐brain barrier (BBB)‐penetrating anti‐amyloid‒β fusion protein
21. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant
22. Assessment of stability of sulphated lactosyl archaeol archaeosomes for use as a vaccine adjuvant.
23. Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
24. Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma
25. Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization
26. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations
27. DYNAMICS OF THE NUCLEUS DURING LYMPHOCYTE ACTIVATION
28. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice
29. An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma
30. Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells1
31. IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heterologous intracellular bacterium
32. Delayed expansion and contraction of CD8+T cell response during infection with virulent Salmonella typhimurium.: J.Immunol
33. Prolonged antigen-presentation, antigen presenting cell- and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes.': J.Immunol
34. Mycobacterium bovis BCG-infected mice are more susceptible to Staphylococcal Enterotoxin B-mediated toxic shock than uninfected Mice despite reduced in vitro splenocyte responses to the superantigens
35. Pre-existing inflammation due to Mycobacterium bovis (BCG) infection differentially modulates T cell priming against a replicating or a non-replicating immunogen.: Infect.Immun
36. Multiple mechanisms compensate to enhance tumor-protective CD8+ T cell response in the long-term despite poor CD8+ T cell priming initially: Comparison between an acute versus a chronic intracellular bacteirum expressing a model antigen.: J.Immunol
37. Cross-reactive antigen is required to prevent erosion of established T cell memory and tumor immunity: A heterologous bacterial model of attrition.: J.Immunol
38. Intrinsic Role of FoxO3a in the Development of CD8+ T Cell Memory
39. CD8+ T Cells Primed in the Periphery Provide Time-Bound Immune-Surveillance to the Central Nervous System
40. IFN-γ Expressed by T Cells Regulates the Persistence of Antigen Presentation by Limiting the Survival of Dendritic Cells
41. IFN-γ Induces the Erosion of Preexisting CD8 T Cell Memory during Infection with a Heterologous Intracellular Bacterium
42. Pathogen Proliferation Governs the Magnitude but Compromises the Function of CD8 T Cells
43. Mutation in the Fas Pathway Impairs CD8+ T Cell Memory
44. Delayed Expansion and Contraction of CD8+ T Cell Response during Infection with Virulent Salmonella typhimurium
45. Reducing the Stimulation of CD8+ T Cells during Infection with Intracellular Bacteria Promotes Differentiation Primarily into a Central (CD62LhighCD44high) Subset
46. Prolonged Antigen Presentation, APC-, and CD8+ T Cell Turnover during Mycobacterial Infection: Comparison with Listeria monocytogenes
47. Cross-Reactive Antigen Is Required to Prevent Erosion of Established T Cell Memory and Tumor Immunity: A Heterologous Bacterial Model of Attrition
48. Mycobacterium bovis BCG-Infected Mice Are More Susceptible to Staphylococcal Enterotoxin B-Mediated Toxic Shock than Uninfected Mice despite Reduced In Vitro Splenocyte Responses to Superantigens
49. Multiple Mechanisms Compensate to Enhance Tumor-Protective CD8+ T Cell Response in the Long-Term Despite Poor CD8+ T Cell Priming Initially: Comparison Between an Acute Versus a Chronic Intracellular Bacterium Expressing a Model Antigen
50. Preexisting Inflammation Due toMycobacterium bovisBCG Infection Differentially Modulates T-Cell Priming against a Replicating or Nonreplicating Immunogen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.